Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE
Open Access
- 27 December 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 352, 577468
- https://doi.org/10.1016/j.jneuroim.2020.577468
Abstract
No abstract availableKeywords
Funding Information
- National Multiple Sclerosis Society
- National Institutes of Health
This publication has 31 references indexed in Scilit:
- Purification of Oligodendrocyte Precursor Cells from Rat Cortices by ImmunopanningCold Spring Harbor Protocols, 2013
- Functional and molecular evidence of myelin‐ and neuroprotection by thyroid hormone administration in experimental allergic encephalomyelitisNeuropathology and Applied Neurobiology, 2012
- Sobetirome: a case history of bench-to-clinic drug discovery and developmentHeart Failure Reviews, 2008
- Behavioral and pathological outcomes in MOG 35–55 experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2008
- Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicityJournal of Neuroscience Research, 2008
- Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosisProceedings of the National Academy of Sciences of the United States of America, 2007
- Thyroid hormone receptors in brain development and functionNature Clinical Practice Endocrinology & Metabolism, 2007
- Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitisProceedings of the National Academy of Sciences of the United States of America, 2002
- Activation of adult human derived microglia by myelin phagocytosis in vitroJournal of Neuroscience Research, 1994
- Cell death and control of cell survival in the oligodendrocyte lineageCell, 1992